Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Johnandrose22on Dec 11, 2020 7:13am

149 Views

Post# 32086637

RE:RE:About NMIBC:

It should also be noted that, in recent studies, those who are diagnosed with bladder cancer are as much as 5 times more at risk to commit suicide than the general population. The imperitive for Theralase to successfully complete this phase II study is paramount in trying to save people’s lives, physically and mentally.

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment